The daily business briefing: November 29, 2021

Stock futures rise after Friday's Omicron-driven sell-off, Moderna says Omicron vaccine could be ready in early 2022, and more

A COVID-19 test site at Heathrow
A COVID-19 test site at Heathrow
(Image credit: Hollie Adams/Getty Images)

1. Stock futures rise after Omicron-fueled sell-off

U.S. stock futures rose early Monday, steadying after Friday's sell-off sparked by concerns about the new Omicron variant of the coronavirus. Futures tied to the Dow Jones Industrial Average and the S&P 500 were up by 0.7 percent and 0.9 percent, respectively, at 6:30 a.m. ET. Futures for the tech-heavy Nasdaq were up by 1.1 percent. All three of the major U.S. indexes plunged by more than 2 percent on Friday. Over the weekend, companies held discussions on how to respond to the Omicron variant, and some investors' concerns eased as a public health official in South Africa described symptoms from Omicron variant infections as mild. Oil prices rose by $3 a barrel, recovering some of Friday's losses.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.